UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
批准号:
10023785
负责人:
KHANDAN KEYOMARSI
金额:
$41.96万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-03 至 2025-08-31
关键词:
AddressAdmission activityBachelor&aposs DegreeBioethicsCancer BiologyCancer CenterCareer ChoiceCareer ExplorationChildhoodCommunicationCommunitiesCommunity Health EducationCommunity OutreachComplementDataDevelopmentDevelopment PlansDoctor&aposs DegreeEarly InterventionEconomicsEducationEnrollmentExposure toFacultyFeedbackFosteringGenerationsGoalsGraduate EducationHealth Care ResearchImmersionIndividualKnowledgeLaboratory ResearchLeadLearningMentorsMinorityMissionOralOutcomePeer ReviewPositioning AttributePrevention educationProcessPublicationsResearchResearch TrainingRoleSTEM careerScienceScience, Technology, Engineering and Mathematics EducationScientistStudentsSupport SystemTimeTrainingTraining ProgramsUnderrepresented MinorityUnderrepresented Studentsanticancer researchbasecancer carecancer health disparitycancer preventioncareercareer awarenesscareer developmentdesigneducation researchexperiencefaculty mentorfamily supporthands on researchhigh schoolhigh school programinnovationinterestintervention programminority communitiesminority scientistminority studentminority undergraduatenoveloutreachposterspreventprogramspublic health relevancerecruitresponsible research conductskill acquisitionskillsstudent trainingsuccesssummer researchundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
As a recognized leader in cancer research,1 MD Anderson Cancer Center is well poised to address a
significant lack of diversity in the cancer research workforce that contributes to considerable disparities.2-6 We
will do so via early intervention programs that foster sustained interest in cancer research in students
underrepresented and minority in Science (URMS). Since 2011, we have directed a summer undergraduate
training program encompassing 345 trainees (from 2011-2018), including 120 URMS. Significantly, outcomes
for URMS and non-minority trainees in our program are indistinguishable; URMS and non-minority alumni are
enrolled in or have completed STEM bachelor’s (98.8% vs 98.1%) and doctoral (both 67.1%) degrees and are
retained in STEM education or workforce (98.3% vs 98.6%, respectively). Built upon these successes, we have
designed a comprehensive cancer research training program for high school and undergraduate URMS via the
R25 YES initiative. In our URMS-focused program, we address major barriers in URMS pursuit and success in
STEM, including: limited 1) research experience, 2) career path knowledge, and 3) scientific identity formation
and exposure to science; 4) underdeveloped professionalism and communication skills; 5) inadequate
research, educational, and career mentoring; and 6) barriers in the graduate application process. Our
proposed UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in
Science) has 3 tracks: full-time, 12-week summer research for 1) high-schoolers and 2) undergraduates and 3)
part-time, 40-week research for undergraduates. Within each track, we propose the following aims to address
the aforementioned barriers: Aim 1) Employ focused URMS recruitment and holistic strategies for program
inclusion, and deliver didactic learning and hands-on cancer research experiences through a cadre of
outstanding mentoring faculty. Aim 2) Develop and deliver individualized mentoring, career exploration,
and professional development that stimulates graduate education and cancer research career pursuit.
Aim 3) Educate and inspire URMS communities, young generations in the STEM pipeline, and the
families and support systems of our students through training, STEM outreach, and hands-on
engagement. We will encourage our trainees to lead and encourage their communities and younger
generations through hands-on STEM outreach activities and design and delivery of community education.
Aim 4) Implement and maintain a rigorous assessment program with continual appraisal and enactment of
novel, evidence-driven best practices derived from these efforts. Lastly, we commit to disseminating our
findings and best practices via peer-reviewed publications. Through the UPWARDS Program, we will build
upon our prior experiences and best practices to launch a cancer research training program specifically
designed to fit the needs of URMS trainees in our local community and nationally. We anticipate our efforts will
effectively increase diversity in the STEM educational pipeline and cancer research workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
-
批准号:10316167
-
项目类别:
-
资助金额:$58.17万
-
财政年份:2020
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
-
批准号:10252909
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2020
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
-
批准号:10097489
-
项目类别:
-
资助金额:$58.75万
-
财政年份:2020
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
-
批准号:10550153
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2018
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
-
批准号:9436336
-
项目类别:
-
资助金额:$39.4万
-
财政年份:2018
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
-
批准号:10337331
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2018
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
-
批准号:10113558
-
项目类别:
-
资助金额:$39.4万
-
财政年份:2018
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Targeting the cell cycle in triple negative breast cancer
-
批准号:8250334
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2011
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Targeting the cell cycle in triple negative breast cancer
-
批准号:8631060
-
项目类别:
-
资助金额:$42.04万
-
财政年份:2011
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Targeting the cell cycle in triple negative breast cancer
-
批准号:8454512
-
项目类别:
-
资助金额:$47.3万
-
财政年份:2011
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Targeting the cell cycle in triple negative breast cancer
-
批准号:8108380
-
项目类别:
-
资助金额:$50.92万
-
财政年份:2011
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Cyclin E as a Novel and Powerful Prognosticator for Breat Cancer
-
批准号:7737049
-
项目类别:
-
资助金额:$16.66万
-
财政年份:2008
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proteolytic processing of cyclin E in breast cancer
-
批准号:7095958
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proteolytic Processing of Cyclin E in Breast Cancer
-
批准号:6788005
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proteolytic processing of cyclin E in breast cancer
-
批准号:7439711
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proteolytic processing of cyclin E in breast cancer
-
批准号:7234113
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proteolytic processing of cyclin E in breast cancer
-
批准号:7617394
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proteolytic processing of cyclin E in breast cancer
-
批准号:7394949
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proeolytic Processing of Cyclin E in Breast Cancer
-
批准号:8207212
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位:
Proeolytic Processing of Cyclin E in Breast Cancer
-
批准号:8585030
-
项目类别:
-
资助金额:$27.79万
-
财政年份:2001
-
负责人:KHANDAN KEYOMARSI
-
依托单位: